Spotlight Asset Group, Inc. Checkpoint Therapeutics, Inc. Transaction History

Spotlight Asset Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	BUY	$2.36 - $3.2 $23,600 - $32,000	10,000 Added 1.53%	661,597 $1.95 Million
Q1 2021 Apr 07, 2021	BUY	$2.6 - $4.16 $1.49 Million - $2.38 Million	571,597 Added 714.5%	651,597 $2.05 Million
Q4 2019 Apr 13, 2020	BUY	$1.18 - $2.39 $94,400 - $191,200	80,000 New	80,000 $110,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $234M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of Spotlight Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Spotlight Asset Group, Inc. with notifications on news.